We are live on
!
Find out more
3C
325 Capital Portfolio holdings
AUM
$274M
1-Year Est. Return
49.96%
This Fund
S&P 500
This Quarter
Est. Return
+14.03%
1 Year Est. Return
+49.96%
3 Year Est. Return
+158.78%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$152M
AUM Growth
+$37.3M
(+33%)
Cap. Flow
+$21.9M
Cap. Flow
% of AUM
14.41%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
5
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biote Corp
BTMD
|
+$10.7M |
| 2 |
Astrana Health
ASTH
|
+$4.53M |
| 3 |
DSKE
Daseke, Inc. Common Stock
DSKE
|
+$3.9M |
| 4 |
Motorcar Parts of America
MPAA
|
+$2.13M |
| 5 |
American Public Education
APEI
|
+$625K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 39.66% |
| 2 | Healthcare | 26.98% |
| 3 | Technology | 18.21% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Consumer Staples | 4.01% |
Similar funds
ACM
MP
PP
JWM
REA
OL
HCM
BWM
325 Capital's Q2 2023 Portfolio in Review
As of Q2 2023, 325 Capital held 9 positions worth $152M, up 33% from $114M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
325 Capital deployed $21.9M of net new capital in Q2 2023, adding to 5 existing holdings.
By sector, the portfolio is most concentrated in Industrials at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.
- 325 Capital added most to Biote Corp in Q2 2023, an estimated $10.7M increase.
- 325 Capital's ten largest holdings make up 100% of its $152M portfolio in Q2 2023.
- 325 Capital opened 0 new positions and closed 0 in Q2 2023.
- 325 Capital's portfolio value rose 33% quarter-over-quarter to $152M.
Based on 325 Capital's 13F filing for Q2 2023, filed 14 Aug 2023.